Public source

Reviewed 11 May 2026

Completeness Good (42%)

SyMRI NEURO

SyntheticMR

The product package SyMRI NEURO includes contrast weighted images as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps. The product is designed to offer the clinician more information than conventional MRI and provide objective decision support for the diagnosis and follow-up of patients.

Supported by 2 papers

Key features

Brain region segmentation

Contrast image synthesis

Degree of myelination

General Information

Product name

SyMRI NEURO

Modality

MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Multiple Sclerosis (MS), atrophy, dementia, Neurodegenerative diseases

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Market Presence

On market since

04-2017

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Jan 30, 2020 | Last updated: May 11, 2026